BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 22236875)

  • 1. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
    Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
    Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.
    Migneco G; Whitaker-Menezes D; Chiavarina B; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Flomenberg N; Tsirigos A; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2010 Jun; 9(12):2412-22. PubMed ID: 20562527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.
    Bonuccelli G; Whitaker-Menezes D; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Witkiewicz AK; Vander Heiden MG; Migneco G; Chiavarina B; Frank PG; Capozza F; Flomenberg N; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2010 May; 9(10):1960-71. PubMed ID: 20495363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.
    Balliet RM; Capparelli C; Guido C; Pestell TG; Martinez-Outschoorn UE; Lin Z; Whitaker-Menezes D; Chiavarina B; Pestell RG; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Dec; 10(23):4065-73. PubMed ID: 22129993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis.
    Avena P; Anselmo W; Whitaker-Menezes D; Wang C; Pestell RG; Lamb RS; Hulit J; Casaburi I; Andò S; Martinez-Outschoorn UE; Lisanti MP; Sotgia F
    Cell Cycle; 2013 May; 12(9):1360-70. PubMed ID: 23574724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.
    Pavlides S; Whitaker-Menezes D; Castello-Cros R; Flomenberg N; Witkiewicz AK; Frank PG; Casimiro MC; Wang C; Fortina P; Addya S; Pestell RG; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2009 Dec; 8(23):3984-4001. PubMed ID: 19923890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.
    Capparelli C; Whitaker-Menezes D; Guido C; Balliet R; Pestell TG; Howell A; Sneddon S; Pestell RG; Martinez-Outschoorn U; Lisanti MP; Sotgia F
    Cell Cycle; 2012 Jun; 11(12):2272-84. PubMed ID: 22684333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
    Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
    Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance.
    Ko YH; Lin Z; Flomenberg N; Pestell RG; Howell A; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cancer Biol Ther; 2011 Dec; 12(12):1085-97. PubMed ID: 22236876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells.
    Martinez-Outschoorn UE; Balliet RM; Rivadeneira DB; Chiavarina B; Pavlides S; Wang C; Whitaker-Menezes D; Daumer KM; Lin Z; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Knudsen ES; Sotgia F; Lisanti MP
    Cell Cycle; 2010 Aug; 9(16):3256-76. PubMed ID: 20814239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.
    Martinez-Outschoorn UE; Pavlides S; Howell A; Pestell RG; Tanowitz HB; Sotgia F; Lisanti MP
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1045-51. PubMed ID: 21300172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
    Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis.
    Castello-Cros R; Bonuccelli G; Molchansky A; Capozza F; Witkiewicz AK; Birbe RC; Howell A; Pestell RG; Whitaker-Menezes D; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Jun; 10(12):2021-34. PubMed ID: 21646868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.
    Trimmer C; Sotgia F; Whitaker-Menezes D; Balliet RM; Eaton G; Martinez-Outschoorn UE; Pavlides S; Howell A; Iozzo RV; Pestell RG; Scherer PE; Capozza F; Lisanti MP
    Cancer Biol Ther; 2011 Feb; 11(4):383-94. PubMed ID: 21150282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
    Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.
    Bonuccelli G; Tsirigos A; Whitaker-Menezes D; Pavlides S; Pestell RG; Chiavarina B; Frank PG; Flomenberg N; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2010 Sep; 9(17):3506-14. PubMed ID: 20818174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.
    Chiavarina B; Whitaker-Menezes D; Migneco G; Martinez-Outschoorn UE; Pavlides S; Howell A; Tanowitz HB; Casimiro MC; Wang C; Pestell RG; Grieshaber P; Caro J; Sotgia F; Lisanti MP
    Cell Cycle; 2010 Sep; 9(17):3534-51. PubMed ID: 20864819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.